SG Americas Securities
BCYC

SG Americas Securities’s Bicycle Therapeutics BCYC Stock Holding History

SG Americas Securities’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,328
Closed -$509K – 3188
2022
Q2 		$509K Sell
30,328
-51
-0.2% -$1.07K 0.01% 1942
2022
Q1 		$1.33M Buy
+30,379
New +$1.42M 0.01% 1222

Other funds holding BCYC

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

SG Americas Securities's BCYC Position: Q3 2022 in Review

SG Americas Securities sold out of Bicycle Therapeutics (BCYC) in Q3 2022, closing a stake of 30,328 shares — an estimated $509K sold.

SG Americas Securities first reported a position in BCYC in Q1 2022 and held it in 2 quarters. The position peaked at $1.33M in Q1 2022. 79 funds tracked by Wall St. Rank hold BCYC as of Q3 2022.

  • SG Americas Securities reported no remaining Bicycle Therapeutics position as of Q3 2022 after selling out during the quarter.
  • SG Americas Securities sold 30,328 Bicycle Therapeutics shares in Q3 2022, an estimated $509K.
  • SG Americas Securities first reported a position in Bicycle Therapeutics in Q1 2022 and held it in 2 quarters.
  • SG Americas Securities's Bicycle Therapeutics position peaked at $1.33M in Q1 2022.
  • 79 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2022.

Based on SG Americas Securities's 13F filing for Q3 2022, filed 31 Oct 2022.